Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    DPP4 Inhibitors for Diabetes and the Risk for Heart Failure

    DPP4 Inhibitors for Diabetes and the Risk for Heart Failure

    FromJAMA Cardiology Author Interviews

    Start listeningView podcast show

    DPP4 Inhibitors for Diabetes and the Risk for Heart Failure

    FromJAMA Cardiology Author Interviews

    ratings:
    Length:
    19 minutes
    Released:
    Apr 13, 2016
    Format:
    Podcast episode

    Description

    Interview with Darren McGuire, MD, author of Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus, and Benjamin Scirica, MD, author of The Safety of Dipeptidyl Peptidase 4 Inhibitors and the Risk for Heart Failure
    Released:
    Apr 13, 2016
    Format:
    Podcast episode

    Titles in the series (100)

    Interviews with authors of articles from JAMA Cardiology. JAMA Cardiology publishes exceptional original research, state-of-the-art reviews, and informative opinions that advance the science and practice of cardiology, enhance cardiovascular health, and inform health care policy. JAMA Cardiology is the definitive journal for clinical investigators, clinicians, and trainees in cardiovascular medicine worldwide. JAMA Cardiology focuses on all aspects of cardiovascular medicine, including epidemiology and prevention, diagnostic testing, interventional and pharmacologic therapeutics, translational research, health care policy and outcomes, and global health.